LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

Search

Adverum Biotechnologies Inc

Closed

SectorHealthcare

4.21 1.2

Overview

Share price change

24h

Current

Min

4.21

Max

4.27

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+15.02% upside

News Sentiment

By Acuity

58%

42%

311 / 374 Ranking in Healthcare

Adverum Biotechnologies Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 paź 2025, 13:04 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Agrees to Acquire Adverum Biotechnologies

24 paź 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY

24 paź 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY

24 paź 2025, 12:33 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY

24 paź 2025, 12:30 UTC

Acquisitions, Mergers, Takeovers

Lilly To Acquire Adverum Biotechnologies >LLY ADVM

Peer Comparison

Price change

Adverum Biotechnologies Inc Forecast

Price Target

By TipRanks

15.02% upside

12 Months Forecast

Average 4.9 USD  15.02%

High 5.5 USD

Low 4 USD

Based on 6 Wall Street analysts offering 12 month price targets forAdverum Biotechnologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

2

Buy

4

Hold

0

Sell

Sentiment

By Acuity

311 / 374 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$

help-icon Live chat